Monday, September 17, 2007

FDA Warns Against Use Of Fentora In Patients With Acute Pain – Linked To Five Deaths – Breakthrough Pain Cancer Drug

Another unfortunate setback for cancer patients. The Fentora, once a promising painkiller for cancer patients, is on the verge of being taken offline.

(Best Syndication) The powerful painkiller, Fentora, which is used for treating pain in cancer patients, is linked to four deaths and a suicide, according to a spokesperson from Cephalon Inc. Fentora contains an ingredient called Fentanyl, which is eighty times more power than Morphine. The drug may have been prescribed for other conditions including migraine headaches, back and bone pain. The company now warns against that.

The Food and Drug Administration (FDA) and the drugs maker warned doctors in a letter. The drug should only be used on cancer patients who are already taking opiod drugs like Morphine. The company wants to make sure that those taking Fentor are tolerant to opiod drugs. The drug should not be prescribed for acute pain or for postoperative pain, according to the letter.



The company says do not substitute Fentora for Actiq or other fentanyl-containing products. Patients should not take more than 2 FENTORA tablets per breakthrough pain (BTP) episode. Patients must wait at leas 4 hours between treatments.

Source: Bestsyndication.com

No comments: